305 related articles for article (PubMed ID: 23090510)
21. Pathophysiological roles for IL-18 in inflammatory arthritis.
Matsui K; Tsutsui H; Nakanishi K
Expert Opin Ther Targets; 2003 Dec; 7(6):701-24. PubMed ID: 14640907
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic effect of an altered peptide ligand derived from heat-shock protein 60 by suppressing of inflammatory cytokines secretion in two animal models of rheumatoid arthritis.
Lorenzo N; Barberá A; Domínguez MC; Torres AM; Hernandez MV; Hernandez I; Gil R; Ancizar J; Garay H; Reyes O; Altruda F; Silengo L; Padrón G
Autoimmunity; 2012 Sep; 45(6):449-59. PubMed ID: 22686732
[TBL] [Abstract][Full Text] [Related]
23. Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis.
Miao J; Zhang K; Lv M; Li Q; Zheng Z; Han Q; Guo N; Fan C; Zhu P
Scand J Rheumatol; 2014; 43(3):194-201. PubMed ID: 24392804
[TBL] [Abstract][Full Text] [Related]
24. Regulation of immune responses by interleukin-27.
Yoshida H; Miyazaki Y
Immunol Rev; 2008 Dec; 226():234-47. PubMed ID: 19161428
[TBL] [Abstract][Full Text] [Related]
25. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
Roeleveld DM; van Nieuwenhuijze AE; van den Berg WB; Koenders MI
BioDrugs; 2013 Oct; 27(5):439-52. PubMed ID: 23620106
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis.
van Hamburg JP; Tas SW
J Autoimmun; 2018 Feb; 87():69-81. PubMed ID: 29254845
[TBL] [Abstract][Full Text] [Related]
27. Update on cytokines in rheumatoid arthritis.
Brennan F; Beech J
Curr Opin Rheumatol; 2007 May; 19(3):296-301. PubMed ID: 17414959
[TBL] [Abstract][Full Text] [Related]
28. [Mouse models for rheumatoid arthritis and their use in drug development].
Iwakura Y
Nihon Yakurigaku Zasshi; 2002 Nov; 120(5):303-13. PubMed ID: 12491806
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-18 and the treatment of rheumatoid arthritis.
Dinarello CA
Rheum Dis Clin North Am; 2004 May; 30(2):417-34, ix. PubMed ID: 15172050
[TBL] [Abstract][Full Text] [Related]
30. Potential route of Th17/T
Karri SK; Sheela A
Br J Biomed Sci; 2017 Jan; 74(1):8-15. PubMed ID: 28074676
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy.
Kramer JM; Gaffen SL
J Periodontol; 2007 Jun; 78(6):1083-93. PubMed ID: 17539723
[TBL] [Abstract][Full Text] [Related]
32. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis.
Chen Z; Bozec A; Ramming A; Schett G
Nat Rev Rheumatol; 2019 Jan; 15(1):9-17. PubMed ID: 30341437
[TBL] [Abstract][Full Text] [Related]
33. Enigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of Arthritis.
Kugyelka R; Kohl Z; Olasz K; Mikecz K; Rauch TA; Glant TT; Boldizsar F
Mediators Inflamm; 2016; 2016():6145810. PubMed ID: 26903711
[TBL] [Abstract][Full Text] [Related]
34. Emerging cytokine targets in rheumatoid arthritis.
Asquith DL; McInnes IB
Curr Opin Rheumatol; 2007 May; 19(3):246-51. PubMed ID: 17414950
[TBL] [Abstract][Full Text] [Related]
35. The biology of IL-23 and IL-17 and their therapeutic targeting in rheumatic diseases.
Sherlock JP; Taylor PC; Buckley CD
Curr Opin Rheumatol; 2015 Jan; 27(1):71-5. PubMed ID: 25415528
[TBL] [Abstract][Full Text] [Related]
36. Highlights in Autoimmunity: 2020.
Toubi E; Vadasz Z
Isr Med Assoc J; 2020 Nov; 11(22):717-719. PubMed ID: 33249794
[TBL] [Abstract][Full Text] [Related]
37. Stepwise regulation of TH1 responses in autoimmunity: IL-12-related cytokines and their receptors.
Becker C; Wirtz S; Neurath MF
Inflamm Bowel Dis; 2005 Aug; 11(8):755-64. PubMed ID: 16043992
[TBL] [Abstract][Full Text] [Related]
38. Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis.
Wang X; Zheng XY; Ma C; Wang XK; Wu J; Adem A; Zhu J; Zhang HL
Scand J Immunol; 2014 Sep; 80(3):180-90. PubMed ID: 24910360
[TBL] [Abstract][Full Text] [Related]
39. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
Abdollahi-Roodsaz S; Joosten LA; Helsen MM; Walgreen B; van Lent PL; van den Bersselaar LA; Koenders MI; van den Berg WB
Arthritis Rheum; 2008 Dec; 58(12):3753-64. PubMed ID: 19035506
[TBL] [Abstract][Full Text] [Related]
40. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
